Filing Details

Accession Number:
0001127602-13-028961
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-10-04 17:13:29
Reporting Period:
2013-10-04
Filing Date:
2013-10-04
Accepted Time:
2013-10-04 17:13:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1520262 Alkermes Plc. ALKS Pharmaceutical Preparations (2834) 981007018
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1529873 L James Botkin 1300 Gould Drive
Gainesville GA 30504
Svp, Alkermes Gainesville Llc No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2013-10-04 11,000 $14.60 13,509 No 4 M Direct
Ordinary Shares Disposition 2013-10-04 11,000 $32.64 2,509 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Employee Stock Option (Right to Buy) Disposition 2013-10-04 11,000 $0.00 11,000 $14.60
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
78,000 2012-10-05 2021-10-05 No 4 M Direct
Footnotes
  1. This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.15 to $32.92. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  4. The option becomes exercisable in three annual installments: 33,000 vesting on 10/5/2012, 33,000 vesting on 10/5/2013 and 34,000 vesting on 10/5/2014.